-+ 0.00%
-+ 0.00%
-+ 0.00%

Lexeo Therapeutics files initial beneficial ownership statement for director Tobin Schilke

PUBT·11/17/2026 22:53:44
Listen to the news
Lexeo Therapeutics files initial beneficial ownership statement for director Tobin Schilke
  • Lexeo Therapeutics director Tobin Schilke filed an initial statement of beneficial ownership on Nov. 17, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lexeo Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001678984-26-000004), on November 17, 2026, and is solely responsible for the information contained therein.